110 related articles for article (PubMed ID: 11832539)
1. B-type natriuretic peptide and acute coronary syndromes.
Biondi-Zoccai GG; Abbate A; Biasucci LM
N Engl J Med; 2002 Feb; 346(6):453-5. PubMed ID: 11832539
[No Abstract] [Full Text] [Related]
2. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
de Lemos JA; Morrow DA; Bentley JH; Omland T; Sabatine MS; McCabe CH; Hall C; Cannon CP; Braunwald E
N Engl J Med; 2001 Oct; 345(14):1014-21. PubMed ID: 11586953
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide and acute coronary syndromes.
Kalra PR; Sharma R; Struthers AD
N Engl J Med; 2002 Feb; 346(6):453-5. PubMed ID: 11837269
[No Abstract] [Full Text] [Related]
4. Brain natriuretic peptide and acute coronary syndrome.
Mazzone M; Forte P; Portale G; Mancini F; Ursella S; La Sala M; Testa A; Covino M; Pignataro G; Gentiloni Silveri N
Minerva Med; 2005 Feb; 96(1):11-8. PubMed ID: 15827538
[TBL] [Abstract][Full Text] [Related]
5. Acute coronary syndromes--beyond myocyte necrosis.
Rabbani LE
N Engl J Med; 2001 Oct; 345(14):1057-9. PubMed ID: 11586960
[No Abstract] [Full Text] [Related]
6. Long reach of the N-terminal of B-type natriuretic peptide.
SoRelle R
Circulation; 2002 Dec; 106(23):e9059. PubMed ID: 12460860
[No Abstract] [Full Text] [Related]
7. [The role of thrombolysis in myocardial infarction (TIMI)risk score in prognosis prediction in senior patient with acute coronary syndromes without ST elevation].
Zhao MZ; Hu DY; Chen XY; Zhu TG; Xu YR
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1103-4. PubMed ID: 15312512
[No Abstract] [Full Text] [Related]
8. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes.
Oltrona L; Ottani F; Galvani M;
Am Heart J; 2004 Sep; 148(3):405-15. PubMed ID: 15389226
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes.
Bayes-Genis A; Conover CA; Overgaard MT; Bailey KR; Christiansen M; Holmes DR; Virmani R; Oxvig C; Schwartz RS
N Engl J Med; 2001 Oct; 345(14):1022-9. PubMed ID: 11586954
[TBL] [Abstract][Full Text] [Related]
10. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice].
James S; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Wallentin L
Lakartidningen; 2004 Apr; 101(17):1514-9, 1521-2. PubMed ID: 15150954
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.
Liuzzo G; Biasucci LM; Gallimore JR; Grillo RL; Rebuzzi AG; Pepys MB; Maseri A
N Engl J Med; 1994 Aug; 331(7):417-24. PubMed ID: 7880233
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.
Wiviott SD; de Lemos JA; Morrow DA
Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312
[TBL] [Abstract][Full Text] [Related]
15. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
Lindahl B; Toss H; Siegbahn A; Venge P; Wallentin L
N Engl J Med; 2000 Oct; 343(16):1139-47. PubMed ID: 11036119
[TBL] [Abstract][Full Text] [Related]
16. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
[TBL] [Abstract][Full Text] [Related]
17. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention.
de Winter RJ; Stroobants A; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; van Straalen JP; Fischer J; Tijssen JG; Piek JJ
Am J Cardiol; 2004 Dec; 94(12):1481-5. PubMed ID: 15589000
[TBL] [Abstract][Full Text] [Related]
18. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy.
Dokainish H; Pillai M; Murphy SA; DiBattiste PM; Schweiger MJ; Lotfi A; Morrow DA; Cannon CP; Braunwald E; Lakkis N;
J Am Coll Cardiol; 2005 Jan; 45(1):19-24. PubMed ID: 15629367
[TBL] [Abstract][Full Text] [Related]
20. [Recommendations for the clinical use of cardiac natriuretic peptides].
Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G
Ital Heart J Suppl; 2005 May; 6(5):308-25. PubMed ID: 15934430
[No Abstract] [Full Text] [Related]
[Next] [New Search]